Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Net Cash Flow (2020 - 2021)

Historic Net Cash Flow for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to -$59.1 million.

  • Design Therapeutics' Net Cash Flow fell 689325.44% to -$59.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $296.2 million, marking a year-over-year increase of 1276663.77%. This contributed to the annual value of $1.4 million for FY2024, which is 12571.7% up from last year.
  • Latest data reveals that Design Therapeutics reported Net Cash Flow of -$59.1 million as of Q4 2021, which was down 689325.44% from -$13.2 million recorded in Q3 2021.
  • Design Therapeutics' Net Cash Flow's 5-year high stood at $398.3 million during Q1 2021, with a 5-year trough of -$59.1 million in Q4 2021.